Correlation Between Anixa Biosciences and Coya Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anixa Biosciences and Coya Therapeutics, Common, you can compare the effects of market volatilities on Anixa Biosciences and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Coya Therapeutics,.

Diversification Opportunities for Anixa Biosciences and Coya Therapeutics,

0.34

Correlation Coefficient

Anixa Biosciences  Coya Therapeutics,

Weak diversification

The 3 months correlation between Anixa and Coya is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between Anixa Biosciences and Coya Therapeutics,

Given the investment horizon of 90 days Anixa Biosciences is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Anixa Biosciences is 1.41 times less risky than Coya Therapeutics,. The stock trades about -0.05 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  587.00  in Coya Therapeutics, Common on September 22, 2024 and sell it today you would lose (63.00) from holding Coya Therapeutics, Common or give up 10.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anixa Biosciences  vs.  Coya Therapeutics, Common

Anixa Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Coya Therapeutics, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Anixa Biosciences and Coya Therapeutics,

The main advantage of trading using opposite Anixa Biosciences and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.

The idea behind Anixa Biosciences and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.